Blue Bell Creameries: We are reassessing everything

By Joseph James Whitworth contact

- Last updated on GMT

A date is not known for when products will return to shelves
A date is not known for when products will return to shelves
Blue Bell Creameries has provided the US Food and Drug Administration (FDA) with corrective actions in response to the agency’s inspection reports.

The FDA released information on inspections at Blue Bell Creameries facilities showing previous Listeria findings.

The company is reviewing all aspects of operations at its Brenham, Texas, Broken Arrow, Oklahoma, and Sylacauga, Alabama, ice cream production facilities.

Enhancements will include updated environmental and product testing procedures.

Blue Bell has entered into agreements with agencies in Alabama, Texas and Oklahoma outlining steps and actions to bring products back to market. 

Paul Kruse, CEO and president, said it is committed to seeing the plan through and working with the FDA.

“Once Blue Bell, the FDA and the applicable state regulators agree we are ready to reintroduce products into commerce, we plan to resume production with a phased-in selection of flavors and sizes, expanding only after our revised programs have demonstrated they are capable of ensuring product safety.”

Meanwhile, the Centers for Disease Control and Prevention (CDC) said the investigation into the outbreak was over as there had been no changes to the case count from April 21.

A total of 10 people infected with several strains of Listeria monocytogenes came from four states.

Blue Bell previously said 1,400 employees will be furloughed, and 750 full-time and 700 part-time employees – or 37% of the total workforce of 3,900 – will be laid off. 

The furloughed employees will be paid a substantial portion of current pay, with the expectation they will return to work as production resumes.

Related topics: Regulation & Safety, Ice Cream

Related news

Show more

Follow us

Products

View more

Webinars